Cost-effectiveness analysis of disease modifiying drugs (interferons and glatiramer acetate) as first line treatments in remitting-relapsing multiple sclerosis patients
- Sánchez-De La Rosa, R.
- Sabater, E.
- Casado, M.A.
- Arroyo, R.
ISSN: 1369-6998, 1941-837X
Argitalpen urtea: 2012
Alea: 15
Zenbakia: 3
Orrialdeak: 424-433
Mota: Artikulua
